Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.

Ying L. Liu,Qin Zhou,Alexia Iasonos,O.T. Filippova,Dennis S. Chi,Oliver Zivanovic,Yukio Sonoda,Ginger J. Gardner,Vance Broach,Roisin O'Cearbhaill,Jason A. Konner,Carol Aghajanian,Kara C. Long-Roche,William P. Tew

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.

2019

Ying L. Liu
Qin Zhou
Alexia Iasonos
O.T. Filippova
Dennis S. Chi
Oliver Zivanovic
Yukio Sonoda
Ginger J. Gardner
Vance Broach
Roisin O'Cearbhaill
Jason A. Konner
Carol Aghajanian
Kara C. Long-Roche
William P. Tew

5552Background: Prolonged time from primary surgery to chemotherapy is associated with worse survival in ovarian cancer (OC); however, the impact of prolonged time from neoadjuvant chemotherapy (NA...

Keywords:

Ovarian cancer
Debulking
Surgery
Medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations